Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guy A Higgins

Showing results (71-80 of 78) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 78 results.
Bioorganic & Medicinal Chemistry Letters|June 19, 2008
Design, synthesis, and evaluation of fused heterocyclic analogs of SCH 58261 as adenosine A2A receptor antagonistsUnmesh Shah, Claire M Lankin, Craig D Boyle, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 3, 2003
PS2APP transgenic mice, coexpressing hPS2mut and hAPPswe, show age-related cognitive deficits associated with discrete brain amyloid deposition and inflammationJ Grayson Richards, Guy A Higgins, Abdel-Mouttalib Ouagazzal, et al.
The Journal of Biological Chemistry|January 8, 2004
Chronic treatment with the gamma-secretase inhibitor LY-411,575 inhibits beta-amyloid peptide production and alters lymphopoiesis and intestinal cell differentiationGwendolyn T Wong, Denise Manfra, Frederique M Poulet, et al.
Psychopharmacology|February 1, 2005
The antinociceptive and anxiolytic-like effects of the metabotropic glutamate receptor 5 (mGluR5) antagonists, MPEP and MTEP, and the mGluR1 antagonist, LY456236, in rodents: a comparison of efficacy and side-effect profilesGeoffrey B Varty, Mariagrazia Grilli, Angelo Forlani, et al.
European Journal of Pharmacology|May 7, 2011
The anxiolytic-like profile of the nociceptin receptor agonist, endo-8-[bis(2-chlorophenyl)methyl]-3-phenyl-8-azabicyclo[3.2.1]octane-3-carboxamide (SCH 655842): comparison of efficacy and side effects across rodent speciesSherry X Lu, Guy A Higgins, Robert A Hodgson, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 2009
Characterization of the potent and highly selective A2A receptor antagonists preladenant and SCH 412348 [7-[2-[4-2,4-difluorophenyl]-1-piperazinyl]ethyl]-2-(2-furanyl)-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine] in rodent models of movement disorders and depressionRobert A Hodgson, Rosalia Bertorelli, Geoffrey B Varty, et al.
International Journal of Alzheimer'S Disease|April 11, 2013
In Vivo Characterization of a Novel γ-Secretase Inhibitor SCH 697466 in Rodents and Investigation of Strategies for Managing Notch-Related Side EffectsLynn A Hyde, Qi Zhang, Robert A Del Vecchio, et al.
Bioorganic & Medicinal Chemistry Letters|October 18, 2018
Novel K<sub>V</sub>7 ion channel openers for the treatment of epilepsy and implications for detrusor tissue contractionMark A Seefeld, Hong Lin, Joerg Holenz, et al.
Pageof 8

Showing results (71-80 of 78) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 78 results.
Bioorganic & Medicinal Chemistry Letters|June 19, 2008
Design, synthesis, and evaluation of fused heterocyclic analogs of SCH 58261 as adenosine A2A receptor antagonistsUnmesh Shah, Claire M Lankin, Craig D Boyle, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 3, 2003
PS2APP transgenic mice, coexpressing hPS2mut and hAPPswe, show age-related cognitive deficits associated with discrete brain amyloid deposition and inflammationJ Grayson Richards, Guy A Higgins, Abdel-Mouttalib Ouagazzal, et al.
The Journal of Biological Chemistry|January 8, 2004
Chronic treatment with the gamma-secretase inhibitor LY-411,575 inhibits beta-amyloid peptide production and alters lymphopoiesis and intestinal cell differentiationGwendolyn T Wong, Denise Manfra, Frederique M Poulet, et al.
Psychopharmacology|February 1, 2005
The antinociceptive and anxiolytic-like effects of the metabotropic glutamate receptor 5 (mGluR5) antagonists, MPEP and MTEP, and the mGluR1 antagonist, LY456236, in rodents: a comparison of efficacy and side-effect profilesGeoffrey B Varty, Mariagrazia Grilli, Angelo Forlani, et al.
European Journal of Pharmacology|May 7, 2011
The anxiolytic-like profile of the nociceptin receptor agonist, endo-8-[bis(2-chlorophenyl)methyl]-3-phenyl-8-azabicyclo[3.2.1]octane-3-carboxamide (SCH 655842): comparison of efficacy and side effects across rodent speciesSherry X Lu, Guy A Higgins, Robert A Hodgson, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 2009
Characterization of the potent and highly selective A2A receptor antagonists preladenant and SCH 412348 [7-[2-[4-2,4-difluorophenyl]-1-piperazinyl]ethyl]-2-(2-furanyl)-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine] in rodent models of movement disorders and depressionRobert A Hodgson, Rosalia Bertorelli, Geoffrey B Varty, et al.
International Journal of Alzheimer'S Disease|April 11, 2013
In Vivo Characterization of a Novel γ-Secretase Inhibitor SCH 697466 in Rodents and Investigation of Strategies for Managing Notch-Related Side EffectsLynn A Hyde, Qi Zhang, Robert A Del Vecchio, et al.
Bioorganic & Medicinal Chemistry Letters|October 18, 2018
Novel K<sub>V</sub>7 ion channel openers for the treatment of epilepsy and implications for detrusor tissue contractionMark A Seefeld, Hong Lin, Joerg Holenz, et al.
Pageof 8